Operational start of PLATINE, a joint immuno-monitoring platform
Innate Pharma to hold its Annual General Meeting of Shareholders on June 23, 2009, in Marseilles, France
Innate Pharma reports preliminary Phase I clinical data for IPH 2101 (a novel, anti-KIR monoclonal antibody activating NK cells) at the ASCO meeting
2008 Reference Document is available
Innate Pharma announces its turnover for the first quarter of 2009 and updates on its cash situation
Innate Pharma appoints Marcel Rozencweig, MD, as Senior Vice President, clinical and regulatory strategy
Innate Pharma updates on its next meetings with analysts and investors
Prestigious award for Alessandro Moretta
P.Pouletty and B.Malissen bring their expertise to innate immunity company
New research laboratories in Marseilles
